These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8093677)

  • 21. Role of P-glycoprotein in dolastatin 10 resistance.
    Toppmeyer DL; Slapak CA; Croop J; Kufe DW
    Biochem Pharmacol; 1994 Aug; 48(3):609-12. PubMed ID: 7915113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
    Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for cyclosporine.
    Ryffel B; Woerly G; Rodriguez C; Foxwell BM
    J Recept Res; 1991; 11(1-4):675-86. PubMed ID: 1679456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug resistance due to P-glycoprotein.
    Burt RK; Fojo AT; Thorgeirsson SS
    Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance.
    Sakata K; Kwok TT; Murphy BJ; Laderoute KR; Gordon GR; Sutherland RM
    Br J Cancer; 1991 Nov; 64(5):809-14. PubMed ID: 1681885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance and P-glycoprotein expression in human cancer.
    Ma DD; Bell DR
    Aust N Z J Med; 1989 Dec; 19(6):736-43. PubMed ID: 2576624
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
    Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
    Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of multidrug resistance in cancer cells.
    Wigler PW
    J Natl Cancer Inst; 1994 Jan; 86(2):148-50. PubMed ID: 7903703
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
    Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equilibrium, kinetic and photoaffinity labeling studies of daunomycin binding to P-glycoprotein-containing membranes of multidrug-resistant Chinese hamster ovary cells.
    Busche R; Tümmler B; Cano-Gauci DF; Riordan JR
    Eur J Biochem; 1989 Jul; 183(1):189-97. PubMed ID: 2568928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.
    Safa AR
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations between natural resistance to doxorubicin, proliferative activity, and expression of P-glycoprotein 170 in human kidney tumor cell lines.
    Efferth T; Löhrke H; Volm M
    Urol Res; 1990; 18(5):309-12. PubMed ID: 1979457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzimidazoles, potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells.
    Nare B; Liu Z; Prichard RK; Georges E
    Biochem Pharmacol; 1994 Dec; 48(12):2215-22. PubMed ID: 7811303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of P-glycoprotein in multidrug resistance malignancies.
    Arceci RJ
    Blood; 1993 May; 81(9):2215-22. PubMed ID: 8097632
    [No Abstract]   [Full Text] [Related]  

  • 35. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs.
    Ling V
    Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966
    [No Abstract]   [Full Text] [Related]  

  • 36. Photoaffinity labeling of P-glycoprotein in multidrug resistant cells with photoactive analogs of colchicine.
    Safa AR; Mehta ND; Agresti M
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1402-8. PubMed ID: 2569869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory aspects of multidrug resistance.
    Fuqua SA; Merkel DE; McGuire WL
    Cancer Treat Res; 1989; 42():45-59. PubMed ID: 2577107
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidrug resistance.
    Tiirikainen MI; Krusius T
    Ann Med; 1991; 23(5):509-20. PubMed ID: 1684512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug resistance.
    Moscow JA; Cowan KH
    J Natl Cancer Inst; 1988 Mar; 80(1):14-20. PubMed ID: 2892943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.